Preliminary unaudited revenue for the fourth quarter of 2022 is expected to be between $143 million and $144 million, an increase of 70% to 71% compared to the fourth quarter of 2021. Fourth quarter 2022 U.S. Coronary preliminary unaudited revenue is expected to be between $81 million and $82 million
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on SWAV:
- Shockwave Medical Announces Agreement to Acquire Neovasc
- Shockwave Medical Provides Quarterly Earnings Release Dates for 2023
- ShockWave selloff presents buying opportunity, says Piper Sandler
- Cardiovascular Systems initiated with an Equal Weight at Barclays
- Wells Fargo cuts ShockWave Medical to Equal Weight, sees growth runway priced in